Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06727890 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Compound Danshen Dripping Pill for Diabetic Microvascular Angina

Study acronym: MVA
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To investigate the efficacy and safety of Compound Danshen Dripping Pill in patients with diabetic microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Compound Danshen Dripping Pill on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Trial Details
NCT Number NCT06727890
Lead Sponsor Qilu Hospital of Shandong University
Conditions
(from sponsor)		 Diabetic Microvascular Angina
Enrollment 162 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov